Article | June 11, 2024

T-Cell Manufacturing: When Is The Right Time To Automate?

Source: Terumo BCT
GettyImages-525799810 Hitachi Retail Automation

Automation enhances efficiency, reduces manual intervention, and decreases variability while simultaneously minimizing contamination risks and labor costs. Despite the initial investment in automation equipment, the long-term savings can be significant. Integrating automation early in the clinical development pipeline is highly advised to prevent delays and complications. When working with T-cell therapies and controlling variabilities more effectively, turning to automation can also assist in managing production complexities. Explore how integrating artificial intelligence (AI) and machine learning for data analysis can further optimize your manufacturing process. Additionally, this change has the potential to expand the accessibility and benefits of T-cell therapies to a larger patient population.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online